Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Aubagio approved in Europe for relapsing-remitting MS

Sep. 2, 2013

Teva will not proceed with Nuvigil regulatory filing in depression following trial results

Sep. 2, 2013

Arizona State University synthesizes new agents for mitochondrial disorders

Sep. 2, 2013

Scientists at Daiichi Sankyo patent new sodium channel blockers

Aug. 30, 2013

Sunovion Pharmaceuticals discloses new antipsychotic agents

Aug. 29, 2013

Orexo updates on OX-51 phase II dose-finding study

Aug. 29, 2013

QRxPharma set to resubmit MoxDuo NDA

Aug. 28, 2013

Epilepsy treatment to be launched in Japan for partial-onset seizures

Aug. 28, 2013

Catalyst obtains FDA breakthrough therapy designation for Firdapse

Aug. 28, 2013

Mount Sinai receives research grant for autism subtype study

Aug. 28, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...